Versant Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-16
| Closed | -$3K | – | 1673 |
|
|
2021
Q2 | $3K | Sell |
16
-21
| -57% | -$3.94K | ﹤0.01% | 1090 |
|
|
2021
Q1 | $6K | Buy |
37
+6
| +19% | +$973 | ﹤0.01% | 992 |
|
|
2020
Q4 | $4K | Hold |
31
| – | – | ﹤0.01% | 1020 |
|
|
2020
Q3 | $3K | Hold |
31
| – | – | ﹤0.01% | 1032 |
|
|
2020
Q2 | $3K | Hold |
31
| – | – | ﹤0.01% | 1021 |
|
|
2020
Q1 | $2K | Sell |
31
-6
| -16% | -$387 | ﹤0.01% | 1078 |
|
|
2019
Q4 | $4K | Sell |
37
-2
| -5% | -$216 | ﹤0.01% | 1040 |
|
|
2019
Q3 | $3K | Hold |
39
| – | – | ﹤0.01% | 1127 |
|
|
2019
Q2 | $5K | Sell |
39
-101
| -72% | -$12.9K | ﹤0.01% | 985 |
|
|
2019
Q1 | $18K | Sell |
140
-11
| -7% | -$1.41K | 0.01% | 679 |
|
|
2018
Q4 | $14K | Hold |
151
| – | – | 0.01% | 704 |
|
|
2018
Q3 | $20K | Hold |
151
| – | – | 0.01% | 653 |
|
|
2018
Q2 | $18K | Hold |
151
| – | – | 0.01% | 678 |
|
|
2018
Q1 | $16K | Sell |
151
-14
| -8% | -$1.48K | 0.01% | 728 |
|
|
2017
Q4 | $19K | Hold |
165
| – | – | 0.01% | 693 |
|
|
2017
Q3 | $23K | Sell |
165
-17
| -9% | -$2.37K | 0.01% | 545 |
|
|
2017
Q2 | $22K | Hold |
182
| – | – | 0.01% | 567 |
|
|
2017
Q1 | $22K | Hold |
182
| – | – | 0.01% | 556 |
|
|
2016
Q4 | $22K | Sell |
182
-69
| -27% | -$8.34K | 0.01% | 563 |
|
|
2016
Q3 | $30K | Sell |
251
-6
| -2% | -$717 | 0.02% | 433 |
|
|
2016
Q2 | $30K | Sell |
257
-7
| -3% | -$817 | 0.02% | 396 |
|
|
2016
Q1 | $36K | Sell |
264
-6
| -2% | -$818 | 0.02% | 323 |
|
|
2015
Q4 | $51K | Buy |
+270
| New | +$51K | 0.03% | 226 |
|